Strategic funding Osigu has recently secured notable funding rounds including a $25M Series B in 2024 led by IDC Ventures with Visa participation, followed by a $10M strategic investment from Eos Ventures in 2025. This shows strong investor confidence and potential appetite for partnerships that align with scale and regional expansion.

Healthcare fintech convergence The company sits at the intersection of healthcare and fintech in Latin America, offering AI-powered revenue cycle management and real-time claims processing. This positions Osigu as a potential partner or supplier to insurers, providers, and pharmaceutical distributors seeking to modernize payments, reduce fraud, and speed patient access.

Regional expansion Osigu has pursued growth through acquisitions and expansion in Latin America, including a notable move to acquire Servinte, a major EHR and healthcare software provider in Colombia. This indicates a strategic appetite for market penetration and could open channels for bundled solutions with health IT ecosystems.

Core capabilities Key capabilities include real-time data exchange, instant claim adjudication, secure automated payments, and fraud prevention. These features align with needs for payers, providers, and suppliers to streamline revenue cycles and improve cash flow, presenting cross-sell opportunities to related health tech and insurance tech ecosystems.

Growth readiness With 51-200 employees, a growing network in healthcare payments, and a revenue trajectory in the low-to-mid single digits with total funding of $52M, Osigu is positioned for partnerships that offer scaling, joint go-to-market activity, or co-development of regional fintech-healthcare solutions targeting Latin America.